✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Vaishali Pharma Ltd.

VAISHALI

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹130 Cr.
P/E
327.79

Vaishali Pharma Ltd.

  • Vaishali Pharma
  • Denis Chem Lab
  • Bal Pharma

FAQs on Vaishali Pharma Ltd. Shareprice

Vaishali Pharma has given lower returns compared to its competitors.
Vaishali Pharma has grown at ~-47.01% over the last 1yrs while peers have grown at a median rate of -22.28%

Vaishali Pharma is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Vaishali Pharma is 327, while 3 year average PE is 109.
Also latest EV/EBITDA of Vaishali Pharma is 0.0 while 3yr average is 124.

View FAQ's On Business

Growth Table

  • Vaishali Pharma Ltd.
  • Denis Chem Lab
  • Bal Pharma

Balance Sheet

  • Vaishali Pharma Ltd.
  • Denis Chem Lab
  • Bal Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Vaishali Pharma Ltd.
  • Denis Chem Lab
  • Bal Pharma

Cash Flow

  • Vaishali Pharma Ltd.
  • Denis Chem Lab
  • Bal Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Vaishali Pharma Ltd.
  • Denis Chem Lab
  • Bal Pharma

Quarterly Results

  • Vaishali Pharma Ltd.
  • Denis Chem Lab
  • Bal Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Vaishali Pharma Ltd. Financials

Balance sheet of Vaishali Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Vaishali Pharma is increasing.
Latest net debt of Vaishali Pharma is ₹9.82 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹9.62 Crs.

The profit is oscillating.
The profit of Vaishali Pharma is ₹0.72 Crs for Mar 2024, ₹6.6 Crs for Mar 2023 and ₹4.02 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vaishali Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech